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SPECT and FDG SPECT on the same day; the early 1"1-201 image obtained 
in the RR protocol was also used as a perfusion study for comparison with 
FDG SPECT. The SPECT data were analyzed semiquantifatively using cir- 
cumferential count profiles, and displayed in polar maps (13 segments). For 
the FDG/TI-2Ol SPECT approach, segments were classified as viable when 
showing normal perfusion or > 7% increased FDG uptake in perfualon de- 
fects (mismatch). For 1"1-201 RR SPECT, cdteda for viability were both the 
percentage of TI-201 uptake and reversibility of defects on the redistribution 
image. Of 312 analyzed segments, 113 had abnormal wall motion at baseline 
and 106 were revasculadzed. Recovery of function was observed in 36 seg- 
ments, whereas 70 segments did not improve. FDG/TI-201 SPECT showed 
sensitivity of 86% (31/36) and a specificity of 77% (54/70) to detect functional 
recovery. TI.201 RR SPECT had a sensitivity of 78% (28/36) and a speci- 
ficity of 59% (41/70). Stepwise logistic regression showed that FDG/TI-201 
SPECT was the single best predictor for functional recovery after revascutar- 
ization. In conclusion, the data suggest that FDG/TI-201 SPECT is superior 
over TI-201 RR SPECT in the identification of segments capable to improve 
in function after revascularization. 
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Video Imaging of Atrial Fibrillation and Defibrillation 
in the Isolated Langendorlf-Perfueed Sheep Heart 
Richard A. Gray, Gregory M. Ayers 1 Josd Jalife. SUNYHealth Science 
Center at Syracuse, NY; 1 InControl, inc, Redmond, WA 
The effects of dstibrillatory shocks on the organization of "electrical activity 
during atrial fibdllation (AF) have not been prsvioualy studied. In addition, the 
reason why some shocks fail and others are successful remains unclear. We 
have studied the events that precede, accompany and follow the application 
of successful, as well as unsuccessful atrial defibriltatory shocks. To this 
aim, we have used h=gh resolution video imaging to record transmembrane 
potentials imultaneously from over 20,000 sites on the epicerdial surface of 
the right and left atrium of the Langendorff-perfused sheep heart (sampling 
rate was either 120 or 240 fremes/soc). We constructed isochrone maps 
dudng sinus rhythm and during AF, as well as following shocks applied by 
a programmable atrial defibdltator. During AF, complete reentrant circuits 
were never observed for more than one beat. In addition breakthrough pat- 
terns of activity were often seen. These results indicate that AF is not a 
two-dimensional phenomenon, but involves transmural propagation. Bipha- 
sic shocks (1.2 ± 0.6 J; n = 6) were delivered through electrodes placed 
in the right atrium and the coronary sinus. These shocks depolarized all 
epicardial regions of the atria and resulted in four types of responses: 1) 
immediate cessation of epicardial activity, 2) a single post-shock activation, 
3) organized activation for 0.8-1.5 seconds followed by termination, end 4) 
organized activity followed by degeneration back into AR Types 2-4 involved 
a quiescent period lasting 110 4- 28 ms immediately following the shock, then 
an activation sequence similar to those observed during sinus rhythm. The 
first cycle length after the shock for types 3 and 4 (170 4- 36 ms) was longer 
than during AF (144 ± 33 ms), These results indicate that the shock de- 
polarized the entire atrial epicardial surface followed by a quiescent peddd 
after which organized activation emanated from the sinoetdal pacemaker 
region. These results are consistent with the "upper limit of vulnerabil~" 
hypothesis. 
1 0:45 
~ I s  It Safe to Deliver Internal Atrial Defibrillation 
Shocks During Single Vessel Myocardial Ischemla? 
Xavier Gonzalez, Gregory M. Ayers, Marina B. Ilina, Darrell O. Wagner, 
William A. Slmkman, Clif A. Alfemess, InControl Inc. Redmond, WA 
Previous work has shown delivery of synchronized low energy Intemal atrial 
defibrillation shocks to terminate atrial fibflllation. We tasted the safety of this 
procedure in association with single vessel myocardial ischemia (SVMI) and 
re-perfusion. 
Methods: In six isofluorane anesthetized sheep (53 4- 9 kg) two leads each 
with a 6 cm distal shocking coil were positioned, one in the coronary sinus 
and one in the right atrium. A bipolar pacing lead was positioned at the right 
vantricular apex for shock synchronization. An atrial defibrillation threshold 
(ADFT) was determined before SVMI. A balloon angtoplasty catheter was 
inflated to occlude the circumflex (CX) artery. Each minute after inflation, 
AF was induced and a shock was delivered at ADFT, two times ADFT if 
the AF persisted and a 300 V shock independent of AF termination. The 
procedure was continued for 15 minutes or until severe ischemia related 
arrhythmlas or hemodynamic hanges were seen. When the balloon was 
deflated, shocks were delivered for the same length of time. After electrocar- 
diographic and hemodynamic recovery, the procedure was repeated in the 
left anterior descending (LAD) artery. Results: 
Groups N # Shocks in AF % Success # Shocks in NSR 
CX inflated 6 76 57 47 
CX deflated 6 44 48 35 
LAD inflated 5 41 49 27 
LAD deflated 5 30 77 31 
A total of 331 shocks were delivered uring SVMI and re-pedusion. None 
of these shocks produced ventricular tschycardia or fibrillation. AF was ter- 
minated in 63% of episodes. Three episodes ~f VF no~, associated with 
shocks were seen immediately after balloon deflation. Conclusions: In this 
model, SVMI does not appear to negatively impact he safety of iofemal atrial 
detibdUation. 
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~ Safety of  Atrial Defibrillation: The Importance of 
Pre-Shock R-R Intervals and the Risk of Premature 
Ventflcular Contractions 
Huagi Li, John Hare, Kashof Mughal, David Krum, Edward T. Keetan, 
Michael BiehL Sanjay Deshpande, Mohammed Jazayeri, Masoed Akhtar. 
Sinai Samaritan Medical Center~St. Luke's Medical Center, Milwaukee, Wl 
Premature ventricutar complexes (PVC) are not uncommon in patients with 
atrial fibrillation (AF). The risk of ventricular tibfillation (VF) induction by 
atrial defibrillation shocks synchronized or coupled with a PVC remains 
unknown and is a great concern for the potential application of implantable 
atrial defibrillators. We determined the safety of internal atrial detibtillation 
shocks (0,8--3.0 J, 3/3 ms biphasic) during AF by selectively synchronizing 
or coupling the shock with the short R-R intervals (< 300 ms) of normal 
QRS complexes and simulated PVCs respectively. AF was produced by 
chronic atrial pacing (400 beats/rain x 4 weeks) in 11 dogs. The short R-R 
interval was selected using a colaputsr system at the baseline and during 
isoproterenol infusion (2 meg/rain). Of the 872 shocks with pre-shock R-R 
interval < 300 ms (243 ± 19 ms), not one induced VF in any dog. However, 
when e shock was synchronized with simulated PVCs of various coupling 
intervals (normal QRS-shock coupling), VF was induced in all dogs. The 
longest normal QRS-PVCIshock interval at VF induction was 186 ± 33 ms 
(145-270) and the VF induction window ((he dic.Hofic inha~ral during which 
VF was inducible) was 34 4-11 ms (20-60). When a shock of various timing 
fuliowed a preceding PVC (PVC-shock coupling), VF was induced over a 
much wider time window (34 4- 11 vs 124 + 27 ms, p < 0.01) in all dogs. 
The longest shock coupling interval (PVC-shock interval) at VF induction was 
extended from 186 4- 33 to 270 • 30 ms (range 220-320, p < 0.01). 
Conclusions: (1) Synchronized atrial defibrillation is safe during AF with 
short R-R intervals if the QRS are all normal. (2) TO avoid synchronizing a
shock with a PVC and the QRS complex immediately following the PVC may 
further improve the safety of internal atrial defibrillation. 
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~ 7  Which Patients Do Benefit From an Implantable 
Atrial Deflbdllator? 
Wemer Jung, Dietrich Pfeiffer, Christian Wolpart, Luciano Pizzulli, 
Wolfgano Fehske, Burghard Schumacher, Thorsten Lewalter, 
Heyder Omran, Thomas Korte, Bemdt LQdedtz. Department of Cardiology 
University of Bonn, Bonn, Germany 
F.xtemal cardioversion has been an effective and safe method for termi- 
nation of atrial fibrillation. Low-energy endocardial cardioversion has been 
suggested as an alternative approach. We report our experience with inter- 
nal atrial defibrillation i  11 consecutive patients (lOtS) with paroxysmal (n = 
4 patients) or chronic (11 = 7 patients) atrial f'd~dltatian. Biphasic shocks were 
synchronized with the R wave and delivered between transvenous catheters 
located in the right atrial appendage and the corenary sinus. The energy of 
the initial shock was 0.5 J and incremented by 0.5 J steps up to a maximum 
of 5 J, Thereafter epeated shocks were delivered with 5 J increments until 
successful conversion. All patients were asked to report pain perception after 
each shock delivery. 
Results: 4 patients uffered from lone atrial fibrillation and 7 patients had 
a structural heart disease. Mean left atrial diameters were 45 -~ 4 ram. 
Duration of atrial fibrillation tasted from 5 days to 450 days (mean 180 4- 
130 days), internal atrial defibrillation was effective in all patients, The mean 
atrial defibrillation threshold was 9.6 4- 6.8 J (range from 0.5 J to 20 J). No 
ventdcular arrhythmias were induced and no other complications occurred. 8 
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of 11 (73%) patients indicated that shocks < 1 J were painful and all required 
sedation at a shock energy level > 2 J. 
Conclusions: (1) Internal atrial defibrillation could be safely and effectively 
performed in all patients in this series. (2) However, only in 36% of the 
patients atrial f~rillation could be terminated with an energy _< 3 J. Thus, 
only a minority of patients may benefit from an Implantable atrial defibrillator 
capable of storing a maximum shock energy of 3 J. (3) Pain perception may 
have a major impact on quality of life in patients with an imptsntable atrial 
defibrillator since the majority of the patients (73%) reported severe pain at 
shock energies < 1 J. 
11:30 
~ Safety of  Transvenoua Atrial Defibril lation in 
Patients With Monomorphic Ventricular Tachycardia 
and Heart Oisease 
Andrea Natale, Margaret M. Keamey, M. Joan Brandon, Mary J. Geiger, 
Helen Barold, Gery Tomeesoni, Virginia Kent, Keith H. Newby. VA Medical 
Center~Duke University,, Durham, NC 
History of ventricular techycardia (VT) and depressed ejection fraction may 
affect ransvenous atrial defibrillation (AD) increasing the likelihood of shock- 
related arrbythmias. In 25 pts with VT (mean age 65 4- 8 years; EF 29 4- 9%) 
we assessed the safety of AD using 2 catheters in the right atrial appendage 
and coronary sinus. In each pt, AD was performed with increasing energy 
starting at 0.5 joules. The protocol was performed both in drug free state 
and during Isoproteren01 infusion. In 5 pts AD was attempted during VT 
and atrial pacing with AV conduction at the same rate of VT. Shocks were 
synchronized using a Medtrenic external defibrillator model 2394. A total of 
398 shocks were analyzed. No ventricular tachyarrhythmias were observed 
after shocks synchronized on the R wave. In 3 pts ventricular fibrillation 
followed inappropriate shocks on the T wave. In all 3 pts, T wave shocking 
was seen only during isoproterenol infusion. Shocks delivered during VT 
always resulted in acceleration of VT (1 pt) or de~,eneretion to VF (4 pts). 
However in the same pts shocks during atrial pacing with ventricular ate 
similar to VT did not induce ventricular arrhythmlas. In conclusion: i} In pts 
with VT transvenous atrial defibrillation is safe when shocks are propedy 
synchronized. 2) Atrial defibrillation during VT appears proarrhythmic. 3) 
Whether lsoprotsrenof infusion increases the likelihood of inappropriate T
wave oversensing needs further evaluation. 
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~ Repeated Internal Low-Energy Cardiovereion of  
Atrial Fibrillation 
Eckhard Ait, Richard Ammer, Claus Schmitt, Jay Pasquantonlo, 
Fred Evans. I. Mad. Kfinik, K#ns~um rechts der Isar, Technical University 
M~nchen, Germany 
Background: The goal of this study was to determine if repeated internal 
cardioversion (intCV) of atrial fibrillation (AF) required the same energy for 
cenvemion as previous successful intCVs. 
Methods: IntCV was successfully performed in 51 of 56 pts by delivering 
3 ms/2 ms biphasic shocks (Ventritex HVS 02, Sunnyvale CA) between 
two custom.made tntracardiac electrode catheters (61=, Elecath Inc., Rahway 
NJ). The shocks ware R-wave triggered, voltage was increased by 40V per 
shock in intervals until sinus rhythm was achieved. Pts were sedated with 
Midazolam. After a mean follow.up of 11 ± 6 months, 20 pts experienced a
second episode of AF. In 8 of these 10ts (age 59 4- 10 years, initial episode 
AF persisting for 7.1 :E 2.5 months, with a mean left atrial echocardiographlc 
diameter of 56.6 ~ 2.4 mm) intCV was attempted a second time after a mean 
AF relapse duration of 1.3:1= 0.9 months. 
Results: Sinus rhythm was restored with a mean energy of 6.4 4- 2.1 J 
(range 1.0-10.2 J) in the first and 3.8 :l: 1.7 J in the second intCV (p < 0.05) 
In all 8 pts. 
:ii T 
.... T 
:l ~IP I:i!}::: ::: ' ,  ;121 
Conclusions: Repeat intCV requires less energy than primary intCV of 
chronic AF given that the second episode is of shorter duration than the first. 
A large number of pts are ineligible for atrial defibrillator implantation due 
to atria[ defibrillation thresholds (DFTs} exceeding the acceptable pain level. 
This study implies that such pts would have considerably lower DFTs, and as 
a result less pain, if their AF was quickly detected and addressed, such as in 
the case of an implanted atrial defibrillator. Therefore, these pts may indeed 
be suitable candidates for atrial defibrillator implantation. 
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[790-1 I In Vivo Nitrate Tolerance Is Not Associated With 
Decreased Production of  Nitric Oxide 
Jom S. Laursen, Alexander Mulsch, Simon Trautner, Petr Mordvintcev, 
Soren Boesgaard, Rudi Busse, Jan Ndershvite. Med. Dept. 8, 
Rigshospitafet, Univ. of Copenhagen, Denmark; Center of Physiology, JW 
Goethe Univ. FrankfurftMain, Germany 
Reduced bioconversion of nitroglycerin (NTG) to nitric P.xide (NO) is regarded 
as a major contributor to the development of nitrate tolerance (Tot). However, 
the validity of this hypothesis has not been examined. We measured produc- 
tion of NO in vascular tissues from nitrate tolerant and non-tolerant rats by in 
vivo spin-trapping of NO. Conscious rats received an Lv. Infusion of NTG (1 
mg/hr, Tel + NTG group, (n ~ 8)) or NTG vehicle. (placebo + NTG group, (n 
= 82) ) for 72 hrs and NO was trapped by d ieethy ld i th io~ate  (DETC) and 
Fe +-citrate during an additional final 20-rain infusion of NTG (6-5 mg/kg), 
Baseline NO production was measured in another group of rats not treated 
with NTG (n = 8, control). Tolerance was documented after 72 h. by an 83% 
reduction in the hypotsnsive response to a NTG bolus (From 24 ± 3 (0 hrs) 
to 2:1: I mmHg ~.72 hre}; p < 0.05). Tissues were removed and analyzed 
for NOFe(DETC)~ complexes by ESR spectroscopy. Data are presented as 
nmot NO/g tissue/20 min. 
Mean (~ Sem) Aorta V. ¢ava Heart NTG Responses 
(ram HO} 
Tel + NTG i18:1:0.3 2.2 =t= 0.3 5.1 4-0.5 24 ~3vs2± 1 
Placebo + NTG 0.9 ± 0.2 1.2:1:0.2 1.7 =t= 0.2 25 .E 3 vs 2 ± 1 
Control 0±0 0±0 0.2±0.01 27:1:3 
The results suggest hat the amounts of NO produced from NTG in homo- 
dynamically nitrate tolerant rats {TeL -*- NTG) are higher or similar to the 
amounts of NO produced in non tolerant rats (placebo + NTG, p < 0.05). 
It is concluded that the in vivo NTG tolerance is not caused by a reduced 
bioconversion of NTG to NO. Instead, tolerance may be associated with a 
reduction of the biological activity of NO. 
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[ "~ '~ Antiplatelet Effect o f  Nitroglycerin Is Primarily 
Mediated by Glutsthlene-a-Transfersses In Human 
Plasma 
Liying Chen, Jawahar L. Mehta. University of Florida, Ga/nesvi/le, FL; VA 
Medical Center, Gainesville, FL 
Current hypothesis relative to the mechanism of action of NTG involves 
metabolic activation of NTG to nitric oxide (NO) by glutathione-s-transferasas 
(GST). Whereas GST metabolizes organic nitrates in the liver, it is unclear if 
these enzymes are present in human plasma or platslets, and are involved 
in the antiplatefet e,'feefs of NTG. We investigated the rote of GST in the 
inhibition of platalet aggregation by NTG. Different concentrations of NTG 
(I-100/~g/ml) were Incubated with platelet-dch plasma or washed platelet 
suspension, and aggregation induced by ADP or thrombin. NTG caused 
a concentration-dependent i hibition of platelet aggregation in platelet.fich 
plasma with ICe0 ~ 50 ~g/mL The aggregation inhibitory effect of NTG 
was not observed in washed platetet suspension, In contrast, authentic NO 
caused about 50% decrease in aggregation in washed platelet suspen- 
sion. The aggregation inhibitory effect of NTG in platelet-ri~ plasma was 
oxyhemnglobin (Hb)-sensitive. The aggregation inhibitory effect of NTG in 
platelet-rich plasma was potentiated by propyithlouracil (600/~g/ml), a GST 
inducer, and antagonized by ketoprofen (100 p.g/mI), a GST inhibitor. These 
phenomena were not observed in washed platslef suspension. Since Hb 
cannot penetrate platalats, revemef of the effect of NTG by Hb must have 
been due to removal of NO from the extracellular medium. This concept 
was confirmed in other studies, wherein NTG (100 #g/ml) increased nitrite 
levels 3 fold in platslet-rich plasma after 60 rain incubation. On the other 
